← Back to headlines
Propanc Biopharma, Inc. Reports GAAP EPS of -$0.30
Propanc Biopharma, Inc. has released its GAAP earnings per share, reporting a loss of $0.30.
18 Feb, 20:42 — 18 Feb, 20:42
Sources
Showing 1 of 1 sources
Related Stories
Boliden to Acquire Majority Stake in Nexa Resources for $1.3 Billion
34m ago
Nvidia Projects 70% Sales Growth Driven by Surging AI Demand
40m ago
US Withdraws Contentious Stance on Canadian Language Protections, Easing Trade Tensions
41m ago
Fed Officials Warn of Persistent Inflation Ahead of Jackson Hole
43m ago